Homepage
Author:
Kalaris Therapeutics, Inc.
Posted Date:
March 17, 2026
Kalaris Reports Full Year 2025 Financial Results and Provides Business Updates
Kalaris Therapeutics, Inc.
March 17, 2026
Kalaris to Present Phase 1 Clinical Data for TH103 at the Macula Society Annual Meeting
Kalaris Therapeutics, Inc.
January 28, 2026
